Strontium ranelate, a promising disease modifying osteoarthritis drug

References

• Hunter DJ, Felson DT. Osteoarthritis. Bmj. 2006 Mar 18;332(7542):639–642.
   PubMed Web of Science ®Google Scholar
• Poole AR. Osteoarthritis as a whole joint disease. Hss J. 2012 Feb;8(1):4–6.
   PubMedGoogle Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Deshpande BR, Katz JN, Solomon DH, et al. The number of persons with symptomatic knee osteoarthritis in the United States: impact of race/ethnicity, age, sex, and obesity. Arthritis Care Res (Hoboken). 2016 Mar 25;68:1743–1750.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465–474.
   PubMed Web of Science ®Google Scholar
• Smelter E, Hochberg MC. New treatments for osteoarthritis. Curr Opin Rheumatol. 2013 May;25(3):310–316.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 2010 Mar;1192:230–237.
   PubMed Web of Science ®Google Scholar
• Roman-Blas JA, Castaneda S, Largo R, et al. An OA phenotype may obtain major benefit from bone-acting agents. Semin Arthritis Rheum. 2014 Feb;43(4):421–428.
   PubMed Web of Science ®Google Scholar
• Bellido M, Lugo L, Roman-Blas JA, et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage. 2011 Oct;19(10):1228–1236.
   PubMed Web of Science ®Google Scholar
• Bellido M, Lugo L, Roman-Blas JA, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010;12(4):R152.
   PubMed Web of Science ®Google Scholar
• Dore D, Martens A, Quinn S, et al. Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther. 2010;12(6):R222.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Zhang W, Conaghan PG, et al. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage. 2011 May;19(5):557–588.
   PubMed Web of Science ®Google Scholar
• Cao Y, Stannus OP, Aitken D, et al. Cross-sectional and longitudinal associations between systemic, subchondral bone mineral density and knee cartilage thickness in older adults with or without radiographic osteoarthritis. Ann Rheum Dis. 2014 Nov;73(11):2003–2009.
   PubMed Web of Science ®Google Scholar
• Barr AJ, Campbell TM, Hopkinson D, et al. A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis. Arthritis Res Ther. 2015;17:228.
   PubMed Web of Science ®Google Scholar
• Marie PJ. Strontium ranelate: new insights into its dual mode of action. Bone. 2007;40(5):S5–S8.
   PubMed Web of Science ®Google Scholar
• Tenti S, Cheleschi S, Guidelli GM, et al. What about strontium ranelate in osteoarthritis? Doubts and securities. Mod Rheumatol. 2014 Nov;24(6):881–884.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Guidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA). 1999.
   Google Scholar
• European Medicines Agency. Guideline on clinical investigation ofmedicinal products used in the treatment of osteoarthritis. 2010.
   Google Scholar
• Reginster JY, Deroisy R, Jupsin I. Strontium ranelate: a new paradigm in the treatment of osteoporosis. Drugs Today (Barc). 2003 Feb;39(2):89–101.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Bay-Jensen AC, Lories RJ, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?. Ann Rheum Dis. 2014 Feb;73(2):336–348.
   PubMed Web of Science ®Google Scholar
• Coulombe J, Faure H, Robin B, et al. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun. 2004 Oct 29;323(4):1184–1190.
   PubMed Web of Science ®Google Scholar
• Chang W, Tu C, Chen TH, et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology. 1999 Dec;140(12):5883–5893.
   PubMed Web of Science ®Google Scholar
• Tat SK, Pelletier JP, Mineau F, et al. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone. 2011 Sep;49(3):559–567.
   PubMed Web of Science ®Google Scholar
• Dg Y, Ding HF, Mao YQ, et al. Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model. Acta Pharmacol Sin. 2013 Mar;34(3):393–402.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Kapoor M, Fahmi H, et al. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1beta in the synovium. Ann Rheum Dis. 2013 Feb;72(2):250–257.
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Labasse A, Zheng SX, et al. Strontium ranelate increases cartilage matrix formation. J Bone Miner Res. 2001 Feb;16(2):299–308.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Protelos, INN-strontium ranelate. 2014. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000560/WC500045525.pdf
   Google Scholar
• Cooper C, Reginster JY, Chapurlat R, et al. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Curr Med Res Opin. 2012 Feb;28(2):231–239.
   PubMed Web of Science ®Google Scholar
• Reginster JY, Badurski J, Bellamy N, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis. 2013 Feb;72(2):179–186.
   PubMed Web of Science ®Google Scholar
• Bruyere O, Reginster JY, Bellamy N, et al. Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. Rheumatology (Oxford). 2014 Aug;53(8):1457–1464.
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Roubille C, Raynauld JP, et al. Disease-modifying effect of strontium ranelate in a subset of patients from the phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann Rheum Dis. 2015 Feb;74(2):422–429.
   PubMed Web of Science ®Google Scholar
• Bruyere O, Delferriere D, Roux C, et al. Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis. 2008 Mar;67(3):335–339.
   PubMed Web of Science ®Google Scholar
• Alexandersen P, Karsdal MA, Byrjalsen I, et al. Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis. Climacteric. 2011 Apr;14(2):236–243.
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Audran M, Bianchi G, et al. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab. 2013 Feb;98(2):592–601.
   PubMed Web of Science ®Google Scholar
• Reginster JY. Cardiac concerns associated with strontium ranelate. Expert Opin Drug Saf. 2014 Sep;13(9):1209–1213.
   PubMed Web of Science ®Google Scholar
• Wang K, Xu J, Hunter DJ, et al. Investigational drugs for the treatment of osteoarthritis. Expert Opin Investig Drugs. 2015;24(12):1539–1556.
   PubMed Web of Science ®Google Scholar
• Clockaerts S, van Osch GJ, Bastiaansen-Jenniskens YM, et al. Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis. 2012 May;71(5):642–647.
   PubMed Web of Science ®Google Scholar